{
  "thread": {
    "uuid": "4d1fd3838c06bedfcd83b59122f155ecadc9046a",
    "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3321176.shtml&from=redirect",
    "site_full": "cj.sina.cn",
    "site": "sina.cn",
    "site_section": "https://finance.sina.cn/?from=redirect",
    "site_categories": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "财经头条_新浪财经_金融信息服务商",
    "title": "昊帆生物股价跌5.02%，汇添富基金旗下1只基金位居十大流通股东，持有86.68万股浮亏损失249.63万元",
    "title_full": "昊帆生物股价跌5.02%，汇添富基金旗下1只基金位居十大流通股东，持有86.68万股浮亏损失249.63万元",
    "published": "2026-01-15T08:12:00.000+02:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CN",
    "main_image": "https://n.sinaimg.cn/finance/c30320b4/20210712/wx_poster_finance1.png",
    "performance_score": 0,
    "domain_rank": 4801,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "4d1fd3838c06bedfcd83b59122f155ecadc9046a",
  "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3321176.shtml&from=redirect",
  "ord_in_thread": 0,
  "author": null,
  "published": "2026-01-15T08:12:00.000+02:00",
  "title": "昊帆生物股价跌5.02%，汇添富基金旗下1只基金位居十大流通股东，持有86.68万股浮亏损失249.63万元",
  "text": "1月15日， 昊帆生物 跌5.02%，截至发稿，报54.50元/股，成交1.07亿元，换手率4.60%，总市值58.86亿元。\n资料显示，苏州昊帆生物股份有限公司位于江苏省苏州高新区长亭路1号，成立日期2003年12月2日，上市日期2023年7月12日，公司主营业务涉及多肽合成试剂、蛋白质交联剂以及分子砌块的研发与销售。主营业务收入构成为：多肽合成试剂81.89%，通用型分子砌块10.99%，蛋白质试剂6.11%，其他产品1.01%。\n从昊帆生物十大流通股东角度\n数据显示，汇添富基金旗下1只基金位居昊帆生物十大流通股东。 汇添富医药保健混合 （470006）三季度 增持 26.43万股，持有股数86.68万股，占流通股的比例为2.06%。根据测算，今日浮亏损失约249.63万元。\n汇添富医药保健混合（470006）成立日期2010年9月21日，最新规模24.86亿。今年以来收益10.53%，同类排名813/8840；近一年收益37.91%，同类排名3262/8094；成立以来收益171.83%。\n汇添富医药保健混合（470006）基金经理为郑磊。\n截至发稿，郑磊累计任职时间11年33天，现任基金资产总规模80.93亿元，任职期间最佳基金回报58.54%， 任职期间最差基金回报-27.52%。\n风险提示：市场有风险， 投资 需谨慎。本文为 AI 大模型 自动发布，任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建议。\nMACD金叉信号形成，这些股涨势不错！\n打开App看更多精彩内容",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->financial and economic news",
    "Economy, Business and Finance->market and exchange"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:16:44.078+02:00",
  "updated": "2026-01-15T08:24:55.000+02:00"
}